Boston Scientific Corp. closed 9.34% short of its 52-week high of $107.17, which the company reached on February 5th.
Boston Scientific’s stock surged 40.6% in the past year, far outpacing the broader market. This growth stems from strong ...
Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...
Boston Scientific gained 1.48% in the latest session, closing at $95.52, while the broader market faced losses. The S&P 500 ...
Boston Scientific BSX has witnessed strong momentum in the past year. Shares of the company have risen 42.4% compared with 8.5% growth of the industry during the same time frame. The S&P 500 Composite ...